385 related articles for article (PubMed ID: 28083883)
1. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Guo W; Zhu T
J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
[TBL] [Abstract][Full Text] [Related]
3.
Penjweini R; Kim MM; Ong YH; Zhu TC
Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
Penjweini R; Kim MM; Liu B; Zhu TC
J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
[TBL] [Abstract][Full Text] [Related]
5. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
Qiu H; Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
[TBL] [Abstract][Full Text] [Related]
6. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
7. Dosimetry study of PHOTOFRIN-mediated photodynamic therapy in a mouse tumor model.
Qiu H; Kim MM; Penjweini R; Zhu TC
Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27053822
[TBL] [Abstract][Full Text] [Related]
8. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
10. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
11. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
Wang KK; Finlay JC; Busch TM; Hahn SM; Zhu TC
J Biophotonics; 2010 Jun; 3(5-6):304-18. PubMed ID: 20222102
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species explicit dosimetry to predict local tumor growth for Photofrin-mediated photodynamic therapy.
Sheng T; Ong Y; Busch TM; Zhu TC
Biomed Opt Express; 2020 Aug; 11(8):4586-4601. PubMed ID: 32923066
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species explicit dosimetry to predict local tumor control for Photofrin-mediated photodynamic therapy.
Sheng T; Ong YH; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10860():. PubMed ID: 31327886
[TBL] [Abstract][Full Text] [Related]
14. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Penjweini R; Liu B; Kim MM; Zhu TC
J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species explicit dosimetry to predict tumor growth for BPD-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10861():. PubMed ID: 31080306
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
17. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
Adams K; Rainbow AJ; Wilson BC; Singh G
J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463
[TBL] [Abstract][Full Text] [Related]
18. In-vivo outcome study of HPPH mediated PDT using singlet oxygen explicit dosimetry (SOED).
Penjweini R; Kim MM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():. PubMed ID: 25999656
[TBL] [Abstract][Full Text] [Related]
19. Assessment of singlet oxygen dosimetry concepts in photodynamic therapy through computational modeling.
Kareliotis G; Liossi S; Makropoulou M
Photodiagnosis Photodyn Ther; 2018 Mar; 21():224-233. PubMed ID: 29292205
[TBL] [Abstract][Full Text] [Related]
20. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
